Global Next-generation Sequencing Service Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Next-generation Sequencing Service Market Insights, Forecast to 2034
Market Analysis and InsightsGlobal Next-generation Sequencing Service Market
Global Next-generation Sequencing Service market is expected to reach to US$ 148 million in 2023, with a positive growth of %, compared with US$ 128 million in 2022. Backed with the increasing demand from downstream industries, Next-generation Sequencing Service industry is evaluated to reach US$ 355 million in 2033. The CAGR will be 15.7% during 2023 to 2033.
Globally, Next-generation Sequencing Service key companies include Illumina, Qiagen N.V., PerkinElmer, Eurofins Scientific S.E., Macrogen, LGC Limited, GENEWIZ, Beijing Genomics Institute and SciGenom Labs, etc. Illumina, Qiagen N.V., PerkinElmer are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Next-generation Sequencing Service were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Next-generation Sequencing Service market and estimated to attract more attentions from industry insiders and investors.
Next-generation Sequencing Service can be divided into DNA and RNA, etc. DNA is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
Next-generation Sequencing Service is widely used in various fields, such as Pharmaceutical, Biotechnology, Academic and Research Institutes and Others, etc. Pharmaceutical provides greatest supports to the Next-generation Sequencing Service industry development. In 2022, global % revenue of Next-generation Sequencing Service went into Pharmaceutical filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Next-generation Sequencing Service market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Next-generation Sequencing Service market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
Illumina
Qiagen N.V.
PerkinElmer
Eurofins Scientific S.E.
Macrogen
LGC Limited
GENEWIZ
Beijing Genomics Institute
SciGenom Labs
MedGenome
Natera
BGI
Roche
LabCorp
Brooks Life Sciences
Novogene
Segment by Type
DNA
RNA
Pharmaceutical
Biotechnology
Academic and Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Next-generation Sequencing Service introduction, etc. Next-generation Sequencing Service Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Next-generation Sequencing Service
Chapter 13Methodology and Data Sources adopted by MRAResearch
Global Next-generation Sequencing Service market is expected to reach to US$ 148 million in 2023, with a positive growth of %, compared with US$ 128 million in 2022. Backed with the increasing demand from downstream industries, Next-generation Sequencing Service industry is evaluated to reach US$ 355 million in 2033. The CAGR will be 15.7% during 2023 to 2033.
Globally, Next-generation Sequencing Service key companies include Illumina, Qiagen N.V., PerkinElmer, Eurofins Scientific S.E., Macrogen, LGC Limited, GENEWIZ, Beijing Genomics Institute and SciGenom Labs, etc. Illumina, Qiagen N.V., PerkinElmer are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Next-generation Sequencing Service were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Next-generation Sequencing Service market and estimated to attract more attentions from industry insiders and investors.
Next-generation Sequencing Service can be divided into DNA and RNA, etc. DNA is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
Next-generation Sequencing Service is widely used in various fields, such as Pharmaceutical, Biotechnology, Academic and Research Institutes and Others, etc. Pharmaceutical provides greatest supports to the Next-generation Sequencing Service industry development. In 2022, global % revenue of Next-generation Sequencing Service went into Pharmaceutical filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Next-generation Sequencing Service market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Next-generation Sequencing Service market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
By Company
Illumina
Qiagen N.V.
PerkinElmer
Eurofins Scientific S.E.
Macrogen
LGC Limited
GENEWIZ
Beijing Genomics Institute
SciGenom Labs
MedGenome
Natera
BGI
Roche
LabCorp
Brooks Life Sciences
Novogene
Segment by Type
DNA
RNA
Segment by Application
Pharmaceutical
Biotechnology
Academic and Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Next-generation Sequencing Service introduction, etc. Next-generation Sequencing Service Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Next-generation Sequencing Service
Chapter 13Methodology and Data Sources adopted by MRAResearch